Lonza Group stock trades near yearly highs as H1 2026 margins improve
Published on 09/02/2026 at 08:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Lonza Group stock (ISIN CH0013841017) is trading close to its recent highs after investors digested improved profitability in the first half of 2026, with the shares changing hands at 578.00 CHF on the SIX Swiss Exchange at 9:28 a.m. local time on September 1, 2026 according to market data reported by Ad Hoc News.
H1 2026 margin gains support valuation
According to the same Ad Hoc News overview summarizing Lonza Group's interim figures, the company reported that in the first half of 2026 its core operating margin improved compared with the prior year period, supported by stronger performance in its research and biologics manufacturing activities, with adjusted earnings before interest and taxes growing faster than revenue in H1 2026 versus H1 2025.
The report notes that Lonza Group's revenue for H1 2026 increased compared with the previous year while profitability improved, indicating that the company generated higher earnings on each unit of sales in the first half of 2026 than in H1 2025, a combination that many investors consider supportive for a premium valuation.
Stock remains just below 52-week high zone
Ad Hoc News highlights that as of the close on August 30, 2026, Lonza Group shares stood at 583.80 CHF on the SIX Swiss Exchange, and subsequent trading around 578.00 CHF on September 1, 2026 kept the stock within a narrow corridor just below its 52-week high zone, leaving the current price level close to the top of its trading range for the past year.
Additional market data compiled by a Swiss large-cap overview show Lonza Group listed under the ticker LONN.SW, with a quotation of 577.80 CHF and a daily move of 0.21 percent as of September 1, 2026, underscoring that the stock is trading in a tight range slightly below the late August closing level.
More reports and analyses on Lonza Group
In the Ad Hoc News topic overview, readers will find further articles, key figures and background information on Lonza Group and its stock.
Biologics manufacturing remains central
Lonza Group is best known for its contract development and manufacturing services in biologics and cell and gene therapies, supplying active ingredients and manufacturing capacity for pharmaceutical and biotechnology companies across Europe, North America and Asia.
Lonza Group stock on the SIX Swiss Exchange
Based on the Ad Hoc News and Swiss market data snapshots, Lonza Group stock is quoted at 578.00 CHF on the SIX Swiss Exchange at 9:28 a.m. local time on September 1, 2026, after closing at 583.80 CHF on August 30, 2026, placing the shares near the upper end of their 52-week trading range heading into early September 2026.
Lonza Group at a glance
- Company: Lonza Group Ltd.
- ISIN: CH0013841017
- Ticker: LONN
- Trading venue: SIX Swiss Exchange
- Price (as of September 1, 2026, 09:28): 578.00 CHF
- Sector / Industry: Healthcare / Life Sciences Tools and Services
- Index membership: SMI
